CAROL RUTH REED
Medical Practice in New Haven, CT
License number
Pennsylvania MD037382E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
2
New Haven, CT 06511
Pennsylvania
Pennsylvania
Personal information
See more information about CAROL RUTH REED at radaris.comName
Address
Phone
468 E Slippery Rock Rd, Chicora, PA 16025
5769 Northeimer Rd, Narvon, PA 17555
5392 Upper Rd, Shamokin, PA 17872
510 Putnam St, Scranton, PA 18508
130 Fairlamb Ave, Havertown, PA 19083
Professional information
Genetic Markers Associated With Response To Antidepressants
US Patent:
2009023, Sep 17, 2009
Filed:
Mar 13, 2008
Appl. No.:
12/077160
Inventors:
Maria Athanasiou - Fond du Lac WI, US
Kerri Holick - Brookfield CT, US
Carol Reed - Bethany CT, US
Benjamin Salisbury - Dayton OH, US
Alessandro Serretti - Bologna, IT
Wei Zou - New Haven CT, US
Kerri Holick - Brookfield CT, US
Carol Reed - Bethany CT, US
Benjamin Salisbury - Dayton OH, US
Alessandro Serretti - Bologna, IT
Wei Zou - New Haven CT, US
International Classification:
A61K 31/497, C12Q 1/68
US Classification:
51425408, 435 6
Abstract:
Markers of the ACE, ATP5C3, BCL2L1, CYP2C9, DRD3, FOS, DTNBP1, GABRG3, GRIA4, LAMA4, MAPK1, NPY1R, OPRD1, OPRM1, PER3, PLCB1, PSMD1, ABI1, LOC402382, and NCALD genes, and their association with response to antidepressants are disclosed. Compositions and methods for detecting and using these markers in a variety of clinical applications are disclosed.
Chrna9 Genetic Markers Associated With Progression Of Alzheimer's Disease
US Patent:
2005025, Nov 17, 2005
Filed:
Nov 22, 2004
Appl. No.:
10/993516
Inventors:
Jeroen Aerssens - Nieuwrode, BE
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
Assignee:
Genaissance Pharmaceuticals - New Haven CT
International Classification:
C12Q001/68, C12P019/34
US Classification:
435006000, 435091200
Abstract:
Haplotypes in the CHRNA9 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these CHRNA9 haplotypes are disclosed.
Cdk5 Genetic Markers Associated With Galantamine Response
US Patent:
2008016, Jul 10, 2008
Filed:
Jul 26, 2007
Appl. No.:
11/878749
Inventors:
Jeroen Aerssens - Nieuwrode, BE
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Rex Denton - Madison CT, US
Richard S. Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol R. Reed - Bethany CT, US
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Rex Denton - Madison CT, US
Richard S. Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol R. Reed - Bethany CT, US
Assignee:
PGxHealth, LLC - New Haven CT
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
Haplotypes in the CDK5 gene associated with cognitive response to galantamine treatment are disclosed. Compositions and methods for detecting and using these CDK5 haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising galantamine or derivatives thereof that are approved for treating patients having one of these CDK5 haplotypes, methods and kits for predicting the response of an individual to galantamine based upon his/her haplotype profile, and methods for treating Alzheimer's patients based upon their haplotype profile.
Ntrk1 Genetic Markers Associated With Age Of Onset Of Alzheimer's Disease
US Patent:
2005025, Nov 17, 2005
Filed:
Oct 13, 2004
Appl. No.:
10/962756
Inventors:
Jeroen Aerssens - Nieuwrode, BE
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
Haplotypes in the NTRK1 gene associated with age of onset of Alzheimer's Disease are disclosed. Compositions and methods for detecting and using these NTRK1 haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising compounds effective in delaying the age of onset of AD in individuals at risk for developing AD and having one of these NTRK1 haplotypes, methods and kits for predicting the age of onset of AD in an individual at risk for developing AD based upon his/her haplotype profile, and methods for delaying the age of onset of AD in individuals at risk for developing AD based upon their haplotype profile.
Ntrk1 Genetic Markers Associated With Progression Of Alzheimer's Disease
US Patent:
2006016, Jul 27, 2006
Filed:
Nov 22, 2004
Appl. No.:
10/993483
Inventors:
Jeroen Aerssens - Nieuwrode, BE
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
Assignee:
Genaissance Pharmaceuticals - New Haven CT
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
Haplotypes in the NTRK1 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these NTRK1 haplotypes are disclosed.
Apoa4 Genetic Markers Associated With Progression Of Alzheimer's Disease
US Patent:
2005025, Nov 10, 2005
Filed:
Nov 22, 2004
Appl. No.:
10/993514
Inventors:
Jeroen Aerssens - Nieuwrode, BE
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
Assignee:
Genaissance Pharmaceuticals - New Haven CT
International Classification:
C12Q001/68, C12P019/34
US Classification:
435006000, 435091200
Abstract:
Haplotypes in the APOA4 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these APOA4 haplotypes are disclosed.
Ldlr Genetic Markers Associated With Age Of Onset Of Alzheimer's Disease
US Patent:
2006015, Jul 13, 2006
Filed:
Jan 14, 2005
Appl. No.:
11/035114
Inventors:
Jeroen Aerssens - Nieuwrode, BE
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
International Classification:
C12Q 1/68
US Classification:
435006000
Abstract:
Haplotypes in the LDLR gene associated: with age of onset of Alzheimer's Disease are disclosed. Compositions and methods for detecting and using these LDLR haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising compounds effective in delaying the age of onset of AD in individuals at risk for developing AD and having one of these LDLR haplotypes, methods and kits for predicting the age of onset of AD in an individual at risk for developing AD based upon his/her haplotype profile, and methods for delaying the age of onset of AD in individuals at risk for developing AD based upon their haplotype profile.
Ntrk2 Genetic Markers Associated With Progression Of Alzheimer's Disease
US Patent:
2005025, Nov 10, 2005
Filed:
Nov 22, 2004
Appl. No.:
10/993509
Inventors:
Jeroen Aerssens - Nieuwrode, BE
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
Assignee:
Genaissance Pharmaceuticals - New Haven CT
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
Haplotypes in the NTRK2 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these NTRK2 haplotypes are disclosed.
Apoe Genetic Markers Associated With Age Of Onset Of Alzheimer's Disease
US Patent:
2005027, Dec 15, 2005
Filed:
Jan 14, 2005
Appl. No.:
11/034771
Inventors:
Jeroen Aerssens - Nieuwrode, BE
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
Haplotypes in the APOE gene associated with age of onset of Alzheimer's Disease are disclosed. Compositions and methods for detecting and using these APOE haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising compounds effective in delaying the age of onset of AD in individuals at risk for developing AD and having one of these APOE haplotypes, methods and kits for predicting the age of onset of AD in an individual at risk for developing AD based upon his/her haplotype profile, and methods for delaying the age of onset of AD in individuals at risk for developing AD based upon their haplotype profile.
Ephx2 Genetic Markers Associated With Galantamine
US Patent:
2005025, Nov 10, 2005
Filed:
Oct 26, 2004
Appl. No.:
10/972766
Inventors:
Jeroen Aerssens - Nieuwrode, BE
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
Maria Athanasiou - Derby CT, US
Carlos Brain - Somerville MA, US
Nadine Cohen - Warren NJ, US
Bradley Dain - Hamden CT, US
R. Denton - Madison CT, US
Richard Judson - Guilford CT, US
Vural Ozdemir - Long Beach CA, US
Carol Reed - Bethany CT, US
International Classification:
C12Q001/68
US Classification:
435006000
Abstract:
Haplotypes in the EPHX2 gene associated with cognitive response to galantamine treatment are disclosed. Compositions and methods for detecting and using these EPHX2 haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising galantamine or derivatives thereof that are approved for treating patients having one of these EPHX2 haplotypes, methods and kits for predicting the response of an individual to galantamine based upon his/her haplotype profile, and methods for treating Alzheimer's patients based upon their haplotype profile.